Research Updates: multiple sclerosis

Below are short extracts from research updates about this subject - select more to read each item.

  1. Issue 232

    KAPLAN and COLLEAGUES, (1)Heller Institute of Medical Research, Sheba Medical Center, Tel-Hashomer, Israel. the authors, in the search for new biomarkers for multiple sclerosis (MS), c1


  2. Issue 232

    EVANS and COLLEAGUES,  (1)Division of Neurology, University of British Columbia, Vancouver, B.C., Canada. conducted a comprehensive review examining the incidence and prevalenc1


  3. Issue 231

    ADELMAN and COLLEAGUES, (1)Fielding School of Public Health, University of California, Los Angeles, CA, USA estimate average annual cost per multiple sclerosis (MS) patient in the US using published estimates from the literature.


  4. Issue 230

    COSSU and COLLEAGUES, (1)Dipartimento di Scienze Biomediche, Sezione di Microbiologia Sperimentale e Clinica, Università di Sassari, Italy. conducted a clinical trial to study r1


  5. Issue 230

    MERO and COLLEAGUES,  (1)Department of Neurology, Oslo University Hospital, Ullevål, and Department of Medical Genetics, University of Oslo, Oslo, Norway searched for genetic differences in multiple sclerosis (MS) relating to the prese1


  6. Issue 230

    LIN and COLLEAGUES,  (1)Menzies Research Institute Tasmania, University of Tasmania, Hobart, Australia searched for rare MS variants utilizing identity-by-descent (IBD) mapping in a large genome-wide association studies (GWAS) dataset.


  7. Issue 230

    AMATYA and COLLEAGUES, (1)Department of Rehabilitation Medicine, Royal Melbourne Hospital, Royal Park Campus, Melbourne, Australia. assessed the effectiveness of various non-pharmacological interventions for the treatment1


  8. Issue 229

    FERNANDEZ and COLLEAGUES,  (1)Hospital Universitario Carlos Haya, 29190 Malaga, Spain. reviewed information regarding biomarkers in multiple 1


  9. Issue 228

    YUSUF and KOSKI, (1)Integrated Program in Neuroscience, McGill University, Montreal, QC H3A 1A1, Canada. conducted a qualitative review to test the hypothesis that changes 1


  10. Issue 228

    BUSTAMANTE and COLLEAGUES, (1)Servei de Neurología/Neuroimmunología. Centre d'Esclerosi Múltiple de Catalunya,  Cemcat. Hospital Universitari Vall dHebron (HUVH), Barcelona, Spain investigated whether the type I interfer1


  11. Issue 228

    HAWTON and COLLEAGUES, (1)Health Economics Group, University of Exeter Medical School, University of Exeter, Exeter, UK. set out to identify all published economic evaluations of MS t1


  12. Issue 227

    KOLASA, Centre for Pharmacoeconomics, University of Warsaw. conducted a systematic review of cost of illness studies to estimate the average annual cost of MS patient and its breakdown.


  13. Issue 227

    REYES and COLLEAGUES, (1)School of Medical Sciences, Edith Cowan University, Joondalup, WA, Australia. assessed evidence regarding the efficacy of inspiratory muscle training (IMT) and ex1


  14. Issue 226

    FILIPPINI and COLLEAGUES,  (1)Neuroepidemiology Unit, Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta, Milano, Italy. studied the relative efficacy and accept1


  15. Issue 225

    PILUTTI and COLLEAGUES, (1)Department of Kinesiology and Community Health, University of Illinois, Urbana, IL 61801, USA examined the effect of exercise training on symptomatic fatigue in persons with  multiple sclerosis (MS).


  16. Issue 224

    FERREIRA and COLLEAGUES, (1)Department of Clinical Analysis and Public Health, Coimbra Health School, Polytechnic Institute of Coimbra, Portugal. review the published literature and ev1


  17. Issue 224

    ALEIXANDRE-BENAVENT and COLLEAGUES, (1)Consejo Superior de Investigaciones Cientificas. Instituto de Historia de la Ciencia, Valencia, Espana. sought to identify scientific coll1


  18. Issue 222

    WENS and COLLEAGUES, (1)REVAL Rehabilitation Research Centre, Biomedical Research Institute, Faculty of Medicine and Life Sciences, Hasselt University, Diepenbeek, Belgium reviewed the literature linking Multiple Sclerosis (MS) to cardiovascular dis1


  19. Issue 221

    KINGWELL and COLLEAGUES, Department of Internal Medicine, University of Manitoba, Winnipeg, Canada. reviewed the clinical literature regarding the incidence, prevalence and methodological 1


  20. Issue 220

    WINGERCHUK and CARTER, (1)Department of Neurology, Mayo Clinic, Scottsdale, AZ. Electronic address:  (2)Department of Neurology, Mayo Clinic, Scottsdale, AZ. Electronic addr1


ICAN Skyscraper

Scientific and Medical Network 2

Cycle Around the World for Charity 2023

Climb Mount Kilimanjaro Charity 2023

Cycle from Milan to Venice for Regain 2023

top of the page